An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas

[31] Saraiva AL(2011)Classification and grading of canine mammary tumors Vet Pathol 48 117-9

[32] Vilhena H(2000)Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay Domest Anim Endocrinol 18 111-63

[33] Miranda S(2005)Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer Gynecol Oncol 98 383-81

[34] Fonseca I(2014)Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma Chin Med J 127 1459-29

[35] Moreira P(1992)Immunocytochemical analysis of estrogen and progestin receptors in uteri of steroid-treated and pregnant cats Biol Reprod 47 1073-8

[36] Alves AM(2005)Hysterographic appearance and uterine histology at different stages of the reproductive cycle and after progestagen treatment in the domestic cat Theriogenology 64 12-45

[37] Paiva R(2001)Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium Biol Reprod 64 831-200

[38] Payan-Carreira R(2014)Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry Vet Pathol 51 127-202

[39] da Costa RM G(2002)Estrogen receptors: structure, mechanisms and function Rev Endocr Metab Disord 3 193-12

[40] Santos M(2013)The estrogen receptor joins other cancer biomarkers as a predictor of outcome Obstet Gynecol Int 10 193-52

[31] Saraiva AL(2011)Classification and grading of canine mammary tumors Vet Pathol 48 117-9

[32] Vilhena H(2000)Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay Domest Anim Endocrinol 18 111-63

[33] Miranda S(2005)Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer Gynecol Oncol 98 383-81

[34] Fonseca I(2014)Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma Chin Med J 127 1459-29

[35] Moreira P(1992)Immunocytochemical analysis of estrogen and progestin receptors in uteri of steroid-treated and pregnant cats Biol Reprod 47 1073-8

[36] Alves AM(2005)Hysterographic appearance and uterine histology at different stages of the reproductive cycle and after progestagen treatment in the domestic cat Theriogenology 64 12-45

[37] Paiva R(2001)Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium Biol Reprod 64 831-200

[38] Payan-Carreira R(2014)Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry Vet Pathol 51 127-202

[39] da Costa RM G(2002)Estrogen receptors: structure, mechanisms and function Rev Endocr Metab Disord 3 193-12

[40] Santos M(2013)The estrogen receptor joins other cancer biomarkers as a predictor of outcome Obstet Gynecol Int 10 193-52